A detailed history of California State Teachers Retirement System transactions in Abb Vie Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 2,888,782 shares of ABBV stock, worth $492 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares
2,888,782
Previous 2,873,984 0.51%
Holding current value
$492 Million
Previous $523 Million 5.33%
% of portfolio
0.62%
Previous 0.67%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $2.29 Million - $2.67 Million
14,798 Added 0.51%
2,888,782 $495 Million
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $3.61 Million - $4.11 Million
22,561 Added 0.79%
2,873,984 $523 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $5.86 Million - $6.6 Million
42,587 Added 1.52%
2,851,423 $442 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $15.4 Million - $17.8 Million
-115,146 Reduced 3.94%
2,808,836 $419 Million
Q2 2023

Aug 21, 2023

SELL
$132.51 - $164.9 $9.18 Million - $11.4 Million
-69,303 Reduced 2.32%
2,923,982 $394 Million
Q1 2023

May 09, 2023

SELL
$144.61 - $166.54 $4.1 Million - $4.72 Million
-28,338 Reduced 0.94%
2,993,285 $477 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $5.81 Million - $6.97 Million
42,023 Added 1.41%
3,021,623 $489 Million
Q3 2022

Nov 18, 2022

SELL
$134.21 - $153.93 $4.68 Million - $5.37 Million
-34,861 Reduced 1.16%
2,979,600 $400 Million
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $172,300 - $219,049
1,252 Added 0.04%
3,014,461 $462 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $23.3 Million - $28.9 Million
-176,723 Reduced 5.54%
3,013,209 $488 Million
Q4 2021

Feb 15, 2022

BUY
$107.43 - $135.93 $78,961 - $99,908
735 Added 0.02%
3,189,932 $432 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $9.59 Million - $10.9 Million
-90,153 Reduced 2.75%
3,189,197 $344 Million
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $19.3 Million - $21.5 Million
-183,649 Reduced 5.3%
3,279,350 $369 Million
Q1 2021

May 18, 2021

SELL
$102.3 - $112.62 $2.02 Million - $2.23 Million
-19,761 Reduced 0.57%
3,462,999 $375 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $3.84 Million - $5.19 Million
47,754 Added 1.39%
3,482,760 $373 Million
Q3 2020

Nov 17, 2020

BUY
$85.91 - $100.83 $650,596 - $763,585
7,573 Added 0.22%
3,435,006 $301 Million
Q2 2020

Aug 17, 2020

BUY
$73.37 - $98.18 $38.7 Million - $51.7 Million
527,027 Added 18.17%
3,427,433 $337 Million
Q1 2020

May 13, 2020

SELL
$64.5 - $97.79 $366,424 - $555,544
-5,681 Reduced 0.2%
2,900,406 $221 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $15.3 Million - $19.1 Million
211,975 Added 7.87%
2,906,087 $257 Million
Q3 2019

Nov 15, 2019

BUY
$62.98 - $75.72 $4.33 Million - $5.2 Million
68,737 Added 2.62%
2,694,112 $204 Million
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $6.31 Million - $8.06 Million
-96,025 Reduced 3.53%
2,625,375 $191 Million
Q1 2019

May 09, 2019

BUY
$77.14 - $90.79 $477,573 - $562,080
6,191 Added 0.23%
2,721,400 $219 Million
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $4.52 Million - $5.57 Million
58,025 Added 2.18%
2,715,209 $250 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $5.69 Million - $6.32 Million
-63,976 Reduced 2.35%
2,657,184 $251 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $251,384 - $297,444
-2,800 Reduced 0.1%
2,721,160 $252 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $7.93 Million - $10.6 Million
-86,141 Reduced 3.07%
2,723,960 $258 Million
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $10.7 Million - $11.7 Million
118,953 Added 4.42%
2,810,101 $272 Million
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $188 Million - $240 Million
2,691,148
2,691,148 $239 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.